- Hamid R. Noori, Central Institute of Mental Health
- Rainer Spanagel, Central Institute of Mental Health
SpringerOpen is Springer’s new suite of open access journals which will cover all disciplines. SpringerOpen journals are fully and immediately open access and will publish articles under the Creative Commons Attribution license. This makes it easy for authors to fully comply with open access mandates and retain copyright. SpringerOpen journals combine open access and our expertise in delivering high-quality and rapid publications, from online submission systems and in-depth peer review to an efficient, author-friendly production process.
Aims & scope
In Silico Pharmacology provides a forum for research articles conceiving the interface between computational and experimental work in pharmacology and toxicology. Primarily, interdisciplinary papers are published that address computational approaches in drug-design and multi-scale analysis of bioactive substances from the cellular up to behavioral level. The journal especially encourages deterministic and stochastic modeling of biological (e.g., biochemical, biophysical and immunological) processes leading to therapeutic advancements as well as mathematical methods characterizing the pharmacology of substances within the living organism. Papers investigating substance- or material-induced morphological and genetic alterations are also welcome. It is anticipated that all computational and experimental approaches are represented within In Silico Pharmacology.